Out-licensing

Messenger Biopharma will not develop its own mRNA products.

We are eager to out-license our Aegis biotechnology to pharmaceutical and biotech companies for vaccine and gene therapy products development.

Last news

photo animalerie 3

Several companies are evaluating Messenger Biopharma’s Aegis biotechnology

posted September 03, 2018

From this Summer on, a ...Read More